BenzingaNovember 10, 2026 at 2:47 AM NY15 Hours Ago
HC Wainwright & Co. Maintains Buy on Tango Therapeutics, Lowers Price Target to $67
HC Wainwright & Co. analyst Robert Burns maintains Tango Therapeutics (NASDAQ:TNGX) with a Buy and lowers the price target from $68 to $67.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
